| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 辅料药(元) | 213,917,874.55 | 299,461,000.70 | 248,895,504.63 | 343,712,017.52 | 306,975,648.90 |
| 药品(元) | 1,925,896,990.05 | - | 2,040,151,215.59 | - | 2,432,695,497.91 |
| 药械智慧供应链(元) | 433,156,463.33 | 777,335,075.12 | 450,823,154.72 | 714,900,959.07 | 390,001,979.38 |
| 医疗器械(元) | 179,852,679.47 | 343,897,969.06 | 172,484,763.02 | 383,123,273.02 | 239,767,299.49 |
| 低分子量肝素钙注射液(元) | - | 176,066,018.44 | - | 287,211,441.36 | - |
| 血必净注射液(元) | - | 935,405,185.86 | - | 851,292,619.74 | - |
| 盐酸莫西沙星氯化钠注射液(元) | - | 159,475,279.56 | - | 189,434,618.73 | - |
| 依诺肝素钠注射液(元) | - | 129,839,189.71 | - | 70,758,625.90 | - |
| 原料药(元) | - | 149,799,406.63 | - | 156,237,280.06 | - |
| 中药配方颗粒(元) | - | 2,668,680,449.98 | - | 2,923,327,269.20 | - |
| 其他(元) | 42,144,262.79 | 142,807,353.65 | 83,879,184.41 | 188,856,544.53 | 54,038,920.16 |
| 营业成本(元) | |||||
| 辅料药(元) | 141,993,054.58 | - | 197,907,379.81 | - | - |
| 药品(元) | 676,789,006.92 | - | 721,500,912.75 | - | - |
| 药械智慧供应链(元) | 399,895,029.80 | 628,140,567.59 | 340,220,046.77 | 542,960,993.33 | 281,941,241.17 |
| 医疗器械(元) | 101,173,098.44 | - | 98,896,873.41 | - | - |
| 低分子量肝素钙注射液(元) | - | - | - | - | - |
| 血必净注射液(元) | - | 157,867,074.94 | - | 110,347,044.98 | - |
| 盐酸莫西沙星氯化钠注射液(元) | - | - | - | - | - |
| 依诺肝素钠注射液(元) | - | - | - | - | - |
| 原料药(元) | - | - | - | - | - |
| 中药配方颗粒(元) | - | 1,057,794,831.47 | - | 1,085,891,863.66 | - |
| 其他(元) | 37,143,415.97 | - | 51,318,290.41 | - | - |
| 毛利(元) | |||||
| 辅料药(元) | 71,924,819.97 | - | 50,988,124.82 | - | - |
| 药品(元) | 1,249,107,983.13 | - | 1,318,650,302.84 | - | - |
| 药械智慧供应链(元) | 33,261,433.53 | 149,194,507.53 | 110,603,107.95 | 171,939,965.74 | 108,060,738.21 |
| 医疗器械(元) | 78,679,581.03 | - | 73,587,889.61 | - | - |
| 低分子量肝素钙注射液(元) | - | - | - | - | - |
| 血必净注射液(元) | - | 777,538,110.92 | - | 740,945,574.76 | - |
| 盐酸莫西沙星氯化钠注射液(元) | - | - | - | - | - |
| 依诺肝素钠注射液(元) | - | - | - | - | - |
| 原料药(元) | - | - | - | - | - |
| 中药配方颗粒(元) | - | 1,610,885,618.51 | - | 1,837,435,405.54 | - |
| 其他(元) | 5,000,846.82 | - | 32,560,894.00 | - | - |
| 毛利率(%) | |||||
| 辅料药(%) | 33.62 | - | 20.49 | - | - |
| 药品(%) | 64.86 | - | 64.63 | - | - |
| 药械智慧供应链(%) | 7.68 | 19.19 | 24.53 | 24.05 | 27.71 |
| 医疗器械(%) | 43.75 | - | 42.66 | - | - |
| 低分子量肝素钙注射液(%) | - | - | - | - | - |
| 血必净注射液(%) | - | 83.12 | - | 87.04 | - |
| 盐酸莫西沙星氯化钠注射液(%) | - | - | - | - | - |
| 依诺肝素钠注射液(%) | - | - | - | - | - |
| 原料药(%) | - | - | - | - | - |
| 中药配方颗粒(%) | - | 60.36 | - | 62.85 | - |
| 其他(%) | 11.87 | - | 38.82 | - | - |
| 收入构成(%) | |||||
| 辅料药(%) | 7.65 | 5.18 | 8.31 | 5.63 | 8.97 |
| 药品(%) | 68.91 | - | 68.09 | - | 71.06 |
| 药械智慧供应链(%) | 15.50 | 13.44 | 15.05 | 11.70 | 11.39 |
| 医疗器械(%) | 6.43 | 5.95 | 5.76 | 6.27 | 7.00 |
| 低分子量肝素钙注射液(%) | - | 3.04 | - | 4.70 | - |
| 血必净注射液(%) | - | 16.18 | - | 13.94 | - |
| 盐酸莫西沙星氯化钠注射液(%) | - | 2.76 | - | 3.10 | - |
| 依诺肝素钠注射液(%) | - | 2.25 | - | 1.16 | - |
| 原料药(%) | - | 2.59 | - | 2.56 | - |
| 中药配方颗粒(%) | - | 46.15 | - | 47.85 | - |
| 其他(%) | 1.51 | 2.47 | 2.80 | 3.09 | 1.58 |
| 毛利构成(%) | |||||
| 辅料药(%) | 5.00 | 0.00 | 3.21 | 0.00 | 0.00 |
| 药品(%) | 86.87 | - | 83.12 | - | 0.00 |
| 药械智慧供应链(%) | 2.31 | 5.88 | 6.97 | 6.25 | 100.00 |
| 医疗器械(%) | 5.47 | 0.00 | 4.64 | 0.00 | 0.00 |
| 低分子量肝素钙注射液(%) | - | 0.00 | - | 0.00 | - |
| 血必净注射液(%) | - | 30.64 | - | 26.94 | - |
| 盐酸莫西沙星氯化钠注射液(%) | - | 0.00 | - | 0.00 | - |
| 依诺肝素钠注射液(%) | - | 0.00 | - | 0.00 | - |
| 原料药(%) | - | 0.00 | - | 0.00 | - |
| 中药配方颗粒(%) | - | 63.48 | - | 66.81 | - |
| 其他(%) | 0.35 | 0.00 | 2.05 | 0.00 | 0.00 |